ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "E1: Age-related Macular Degeneration"
Episode Synopsis
Peter Kaiser, MD, and Jeffrey Heier, MD, examine the findings of the Novartis-appointed Safety Review Committee’s independent assessment of post-marketing cases of inflammation following the approval of brolucizumab.
More episodes of the podcast Retinal Physician Insider
E11: The Treatment of Diabetic Retinopathy
19/01/2022
E10: The Port Delivery System and Wet AMD
17/11/2021
E9: Treatment Options in the Covid Era
29/10/2021
E7: Genentech’s New Port Delivery System
30/08/2021
E6: Closing Macular Holes
01/07/2021
E5: Changes in Diabetic Retinopathy
25/05/2021
In God we trust